These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16951148)

  • 1. Hyperplasia and carcinomas in Pten-deficient mice and reduced PTEN protein in human bladder cancer patients.
    Tsuruta H; Kishimoto H; Sasaki T; Horie Y; Natsui M; Shibata Y; Hamada K; Yajima N; Kawahara K; Sasaki M; Tsuchiya N; Enomoto K; Mak TW; Nakano T; Habuchi T; Suzuki A
    Cancer Res; 2006 Sep; 66(17):8389-96. PubMed ID: 16951148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential PTEN protein expression profiles in superficial versus invasive bladder cancers.
    Koksal IT; Yasar D; Dirice E; Usta MF; Karauzum S; Luleci G; Baykara M; Sanlioglu S
    Urol Int; 2005; 75(2):102-6. PubMed ID: 16123561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptor 3 activation plays a causative role in urothelial cancer pathogenesis in cooperation with Pten loss in mice.
    Foth M; Ahmad I; van Rhijn BW; van der Kwast T; Bergman AM; King L; Ridgway R; Leung HY; Fraser S; Sansom OJ; Iwata T
    J Pathol; 2014 Jun; 233(2):148-58. PubMed ID: 24519156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation.
    Suzuki A; Itami S; Ohishi M; Hamada K; Inoue T; Komazawa N; Senoo H; Sasaki T; Takeda J; Manabe M; Mak TW; Nakano T
    Cancer Res; 2003 Feb; 63(3):674-81. PubMed ID: 12566313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.
    Makboul R; Refaiy A; Abdelkawi IF; Hameed DA; Elderwy AA; Shalaby MM; Merseburger AS; Hussein MR
    Pathol Res Pract; 2016 May; 212(5):385-92. PubMed ID: 26916953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.
    Horie Y; Suzuki A; Kataoka E; Sasaki T; Hamada K; Sasaki J; Mizuno K; Hasegawa G; Kishimoto H; Iizuka M; Naito M; Enomoto K; Watanabe S; Mak TW; Nakano T
    J Clin Invest; 2004 Jun; 113(12):1774-83. PubMed ID: 15199412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genes correlated with early-stage bladder cancer progression.
    Stone R; Sabichi AL; Gill J; Lee IL; Adegboyega P; Dai MS; Loganantharaj R; Trutschl M; Cvek U; Clifford JL
    Cancer Prev Res (Phila); 2010 Jun; 3(6):776-86. PubMed ID: 20501863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro.
    Aaltonen V; Boström PJ; Söderström KO; Hirvonen O; Tuukkanen J; Nurmi M; Laato M; Peltonen J
    Am J Pathol; 1999 Mar; 154(3):755-65. PubMed ID: 10079253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
    Kulac I; Arslankoz S; Netto GJ; Ertoy Baydar D
    Virchows Arch; 2018 Jun; 472(6):969-974. PubMed ID: 29368083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner.
    Yoo LI; Liu DW; Le Vu S; Bronson RT; Wu H; Yuan J
    Cancer Res; 2006 Feb; 66(4):1929-39. PubMed ID: 16488991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biology of urothelial tumorigenesis: insights from genetically engineered mice.
    Wu XR
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):281-90. PubMed ID: 20012171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth.
    Ford-Hutchinson AF; Ali Z; Lines SE; Hallgrímsson B; Boyd SK; Jirik FR
    J Bone Miner Res; 2007 Aug; 22(8):1245-59. PubMed ID: 17456009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
    Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
    Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p63 expression is associated with tumor progression in bladder cancer.
    Urist MJ; Di Como CJ; Lu ML; Charytonowicz E; Verbel D; Crum CP; Ince TA; McKeon FD; Cordon-Cardo C
    Am J Pathol; 2002 Oct; 161(4):1199-206. PubMed ID: 12368193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis.
    Inoue-Narita T; Hamada K; Sasaki T; Hatakeyama S; Fujita S; Kawahara K; Sasaki M; Kishimoto H; Eguchi S; Kojima I; Beermann F; Kimura T; Osawa M; Itami S; Mak TW; Nakano T; Manabe M; Suzuki A
    Cancer Res; 2008 Jul; 68(14):5760-8. PubMed ID: 18632629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.